Literature DB >> 15227389

Trimethoprim- sulfamethoxazole: pharmacokinetics, clinical uses, and adverse reactions.

M A Kielhofner1.   

Abstract

Entities:  

Year:  1990        PMID： 15227389      PMCID： PMC326458     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


× No keyword cloud information.
  56 in total

1.  Aseptic meningitis as an adverse effect of co-trimoxazole.

Authors:  I Kremer; R Ritz; F Brunner
Journal:  N Engl J Med       Date:  1983-06-16       Impact factor: 91.245

2.  Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients.

Authors:  H Jick
Journal:  Rev Infect Dis       Date:  1982 Mar-Apr

Review 3.  Trimethoprim-sulfamethoxazole for bacterial meningitis.

Authors:  R E Levitz; R Quintiliani
Journal:  Ann Intern Med       Date:  1984-06       Impact factor: 25.391

4.  Activity of trimethoprim (TMP), sulphamethoxazole (SMX) and the combination against Bacteroides fragilis group isolates.

Authors:  G L Jackson-York; B B Gump; D W Gump
Journal:  J Antimicrob Chemother       Date:  1983-11       Impact factor: 5.790

5.  Single-dose therapy with trimethoprim-sulfamethoxazole for urinary tract infection in women.

Authors:  N E Tolkoff-Rubin; D Weber; L S Fang; M Kelly; R Wilkinson; R H Rubin
Journal:  Rev Infect Dis       Date:  1982 Mar-Apr

6.  Long-term antimicrobial prophylaxis for recurrent urinary tract infection in women.

Authors:  G K Harding; A R Ronald; L E Nicolle; M J Thomson; G J Gray
Journal:  Rev Infect Dis       Date:  1982 Mar-Apr

7.  Treatment of concomitant Neisseria gonorrhoeae and Chlamydia trachomatis infections in women: comparison of trimethoprim-sulfamethoxazole with ampicillin-probenecid.

Authors:  R C Brunham; C Kuo; C E Stevens; K K Holmes
Journal:  Rev Infect Dis       Date:  1982 Mar-Apr

8.  Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid.

Authors:  J C Wade; C A de Jongh; K A Newman; J Crowley; P H Wiernik; S C Schimpff
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

9.  Trimethoprim-sulfamethoxazole for the treatment of Pneumocystis carinii pneumonia.

Authors:  D J Winston; W K Lau; R P Gale; L S Young
Journal:  Ann Intern Med       Date:  1980-06       Impact factor: 25.391

10.  Pharmacokinetics of trimethoprim and sulfamethoxazole in serum and cerebrospinal fluid of adult patients with normal meninges.

Authors:  M N Dudley; R E Levitz; R Quintiliani; J M Hickingbotham; C H Nightingale
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191
View more
  9 in total

1.  Prospective, open-label investigation of the pharmacokinetics of daptomycin during cardiopulmonary bypass surgery.

Authors:  Megan H Nguyen; Samantha J Eells; Jennifer Tan; Corinne T Sheth; Bassam Omari; Margarita Flores; Jeffrey Wang; Loren G Miller
Journal:  Antimicrob Agents Chemother       Date:  2011-03-28       Impact factor: 5.191

2.  Drug-dependent clearance of human platelets in the NOD/scid mouse by antibodies from patients with drug-induced immune thrombocytopenia.

Authors:  Daniel W Bougie; Dhirendra Nayak; Brian Boylan; Peter J Newman; Richard H Aster
Journal:  Blood       Date:  2010-06-29       Impact factor: 22.113

3.  Anti-proliferative effects of the combination of Sulfamethoxazole and Quercetin via caspase3 and NFkB gene regulation: an in vitro and in vivo study.

Authors:  Heba Abd Elghany Sahyon; Eman N M Ramadan; Fayez Althobaiti; Mohammad M A Mashaly
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-01-07       Impact factor: 3.000

4.  Practical issues with high dose methotrexate therapy.

Authors:  Osama M Al-Quteimat; Mariam A Al-Badaineh
Journal:  Saudi Pharm J       Date:  2014-04-13       Impact factor: 4.330

5.  In vitro activity of antifolate and polymorphism in dihydrofolate reductase of Plasmodium falciparum isolates from the Kenyan coast: emergence of parasites with Ile-164-Leu mutation.

Authors:  Steven M Kiara; John Okombo; Victor Masseno; Leah Mwai; Isabella Ochola; Steffen Borrmann; Alexis Nzila
Journal:  Antimicrob Agents Chemother       Date:  2009-06-15       Impact factor: 5.191

6.  Comparison of oral, nebulized and combination antibiotic treatment of Bordetella bronchiseptica in baboons (Papio spp.).

Authors:  Elizabeth A Clemmons; Deborah Chavez; Laura Condel; John W Dutton; Sharon Price; Robert Lanford
Journal:  J Vet Pharmacol Ther       Date:  2021-05-08       Impact factor: 1.567

7.  Whole animal automated platform for drug discovery against multi-drug resistant Staphylococcus aureus.

Authors:  Rajmohan Rajamuthiah; Beth Burgwyn Fuchs; Elamparithi Jayamani; Younghoon Kim; Jonah Larkins-Ford; Annie Conery; Frederick M Ausubel; Eleftherios Mylonakis
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

Review 8.  Flavin-Dependent Thymidylate Synthase as a New Antibiotic Target.

Authors:  Michael Choi; Kalani Karunaratne; Amnon Kohen
Journal:  Molecules       Date:  2016-05-20       Impact factor: 4.411

9.  Mechanisms Underpinning Increased Plasma Creatinine Levels in Patients Receiving Vemurafenib for Advanced Melanoma.

Authors:  Charlotte Hurabielle; Evangéline Pillebout; Thomas Stehlé; Cécile Pagès; Jennifer Roux; Pierre Schneider; Sylvie Chevret; Cendrine Chaffaut; Anne Boutten; Samia Mourah; Nicole Basset-Seguin; Emmanuelle Vidal-Petiot; Céleste Lebbé; Martin Flamant
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.